Macular Chats

This event featured Jill Adelman and Liz Tully, both of whom are living with AMD. The guests shared helpful tips regarding doctors and specialists that assist with vision loss and shared the physical and psychological challenges of living with AMD.

This event featured Jill Adelman and Liz Tully, both of whom are living with AMD. The guests shared helpful tips regarding doctors and specialists that assist with vision loss and shared the physical and psychological challenges of living with AMD.

he event featured experts including Moshe Vardi, Vice President and Global Medicine Team Lead at Alexion Pharmaceuticals, and Aleksandar Skuban, MD, Executive Medical Director for Neurology and Ophthalmology Clinical Development and Translational Sciences at Alexion Pharmaceuticals, Inc. Dr. Vardi explained the role of the immune system as it relates to GMD, or geographical atrophy. Dr. Skuban talked about studies being done to determine efficacy of new treatments, including danicopan, for GMD.

he event featured experts including Moshe Vardi, Vice President and Global Medicine Team Lead at Alexion Pharmaceuticals, and Aleksandar Skuban, MD, Executive Medical Director for Neurology and Ophthalmology Clinical Development and Translational Sciences at Alexion Pharmaceuticals, Inc. Dr. Vardi explained the role of the immune system as it relates to GMD, or geographical atrophy. Dr. Skuban talked about studies being done to determine efficacy of new treatments, including danicopan, for GMD.

The event featured Joshua Dunaief, M.D., Ph.D., who provided an overview of Age-related Macular Degeneration (AMD) including prevention and treatment. There was specific discussion about overall vision health, new therapies, and which populations are more susceptible to AMD.

The event featured Joshua Dunaief, M.D., Ph.D., who provided an overview of Age-related Macular Degeneration (AMD) including prevention and treatment. There was specific discussion about overall vision health, new therapies, and which populations are more susceptible to AMD.

The event featured Arshad M. Khanani, MD, who provided an overview of Age-related Macular Degeneration (AMD) including an explanation on how gene therapy is being utilized. There was specific discussion about overall vision health, new therapies, and which populations are most susceptible to AMD.

The event featured Arshad M. Khanani, MD, who provided an overview of Age-related Macular Degeneration (AMD) including an explanation on how gene therapy is being utilized. There was specific discussion about overall vision health, new therapies, and which populations are most susceptible to AMD.

La conversación presenta a Sheldon Rowan, PhD del Centro de Investigación de Nutrición Humana sobre el Envejecimiento de USDA (Departamento de agricultura de los Estados Unidos), de la universidad de Tufts. La investigación del Dr. Rowan examina el impacto de la calidad de los carbohidratos en la dieta sobre la degeneración macular relacionada con la edad.